Deltec Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Deltec Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.22M	Buy	14,000 +4,000	+40%	+$541K	0.33%	53
2026 Q1	$1.28M	Hold	10,000	–	–	0.23%	63
2025 Q4	$1.22M	Buy	+10,000	New	+$1.15M	0.2%	73
2023 Q4	–	Sell	-36,200	Closed	-$2.64M	–	171
2023 Q3	$2.64M	Buy	36,200 +8,000	+28%	+$639K	0.6%	43
2023 Q2	$2.35M	Buy	+28,200	New	+$2.36M	0.51%	50
2022 Q2	–	Sell	-6,500	Closed	-$584K	–	261
2022 Q1	$584K	Hold	6,500	–	–	0.1%	137
2021 Q4	$728K	Hold	6,500	–	–	0.12%	131
2021 Q3	$817K	Hold	6,500	–	–	0.12%	126
2021 Q2	$880K	Buy	6,500 +3,000	+86%	+$394K	0.12%	136
2021 Q1	$475K	Hold	3,500	–	–	0.07%	210
2020 Q4	$493K	Hold	3,500	–	–	0.08%	169
2020 Q3	$390K	Hold	3,500	–	–	0.07%	165
2020 Q2	$392K	Sell	3,500 -9,900	-74%	-$975K	0.08%	145
2020 Q1	$1.04M	Sell	13,400 -6,100	-31%	-$540K	0.29%	61
2019 Q4	$1.85M	Sell	19,500 -25,700	-57%	-$2.22M	0.38%	54
2019 Q3	$3.45M	Sell	45,200 -7,500	-14%	-$623K	0.87%	32
2019 Q2	$4.62M	Buy	52,700 +31,200	+145%	+$2.66M	1.01%	24
2019 Q1	$1.95M	Buy	+21,500	New	+$1.83M	0.43%	54
2017 Q2	–	Sell	-72,000	Closed	-$4.99M	–	182
2017 Q1	$4.99M	Buy	+72,000	New	+$4.84M	1.02%	34

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Deltec Asset Management's XBI Position: Q2 2026 in Review

Deltec Asset Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 40% in Q2 2026, buying an estimated $541K and bringing the position to 14,000 shares worth $2.22M. The position accounts for 0.33% of the portfolio, ranked #53.

Deltec Asset Management first reported a position in XBI in Q1 2017 and has held it in 19 quarters since. The position peaked at $4.99M in Q1 2017. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Deltec Asset Management held 14,000 shares of State Street SPDR S&P Biotech ETF worth $2.22M as of Q2 2026.
Deltec Asset Management bought 4,000 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $541K.
State Street SPDR S&P Biotech ETF made up 0.33% of Deltec Asset Management's portfolio in Q2 2026, its #53 holding.
Deltec Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 19 quarters since.
Deltec Asset Management's State Street SPDR S&P Biotech ETF position peaked at $4.99M in Q1 2017.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Deltec Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.